T/JSXH 0007-2025 Greenhouse gases — Quantification methods and requirements for carbon footprint of products — Chemical Drug ( Tablets )

Scope

This document specifies the methods and requirements for quantifying the carbon footprint of pharmaceutical tablet products, including the purpose of quantification, the scope of quantification, inventory analysis, impact evaluation, interpretation of results, product carbon footprint reporting, and product carbon footprint declarations. This document applies to the quantification of the carbon footprint of pharmaceutical tablet products. The results can be applied to different scenarios, and veterinary drugs can be used as a reference. Carbon offsetting and the exchange of product carbon footprint or partial product carbon footprint information are not within the scope of this document. This document only addresses a single impact type, namely climate change. It does not evaluate other potential environmental impacts of the product life cycle, nor does it evaluate the social and economic impacts that may occur during the product life cycle. The purpose of conducting a carbon footprint study for tablet products is to combine the system boundaries and trade-off criteria, quantify all significant greenhouse gas emissions and removals in the relevant stages of the tablet product life cycle, and calculate the potential contribution of tablet products to global warming [expressed in carbon dioxide equivalents (CO2e)], thereby effectively promoting the green transformation and industrial upgrading of the pharmaceutical tablet industry.

Development Information

Related Standards